Vienna Insurance Group: The international rating agency Standard & Poor's (S&P) once again confirmed Vienna Insurance Group's (VIG) rating of "A+" with a stable outlook in its press release on 1 December 2022. As in the previous year, the rating agency considers the financial risk profile of Vienna Insurance Group to be very strong. Once again S&P continues to view VIG's excellent capital adequacy to be a relative ratings strength.VIG: weekly performance: -3.06%Valneva: Valneva and Pfizer reported antibody persistence data six months after the completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination schedule with their Lyme disease vaccine candidate, VLA15 in both children and adults. This is the first time antibody persistence data are reported in ...Den vollständigen Artikel lesen ...
VALNEVA-Aktie komplett kostenlos handeln - auf Smartbroker.de